Legal & General Group’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,749
| Closed | -$40K | – | 3543 |
|
|
2020
Q4 | $40K | Sell |
1,749
-44
| -2% | -$1.01K | ﹤0.01% | 2867 |
|
|
2020
Q3 | $18K | Sell |
1,793
-487
| -21% | -$4.89K | ﹤0.01% | 3015 |
|
|
2020
Q2 | $34K | Buy |
2,280
+134
| +6% | +$2K | ﹤0.01% | 2843 |
|
|
2020
Q1 | $26K | Buy |
2,146
+716
| +50% | +$8.68K | ﹤0.01% | 2822 |
|
|
2019
Q4 | $23K | Buy |
1,430
+228
| +19% | +$3.67K | ﹤0.01% | 3148 |
|
|
2019
Q3 | $15K | Buy |
+1,202
| New | +$15K | ﹤0.01% | 3207 |
|